Non-Replicating Vaccinia Virus NTV as an Effective Next-Generation Smallpox and Monkeypox Vaccine: Evidence from Mouse and Rhesus Monkey Models

Smallpox vaccination‐elicited antibodies cross‐neutralize 2022‐Monkeypox virus Clade II

(2023) Elena Criscuolo et al.   JOURNAL OF MEDICAL VIROLOGY

Global monkeypox outbreak

(2022) Priya Venkatesan   LANCET INFECTIOUS DISEASES

Residual Humoral Immunity Sustained Over Decades in a Cohort of Vaccinia-Vaccinated Individuals

(2022) Conrad E Z Chan et al.   JOURNAL OF INFECTIOUS DISEASES

Low levels of monkeypox virus neutralizing antibodies after MVA-BN vaccination in healthy individuals

(2022) Luca M. Zaeck et al.   NATURE MEDICINE

One- and Two-Dose Vaccinations With Modified Vaccinia Ankara-Bavarian Nordic Induce Durable B-Cell Memory Responses Comparable to Replicating Smallpox Vaccines

(2022) Heiko Ilchmann et al.   JOURNAL OF INFECTIOUS DISEASES

Humoral and cellular immunity against both ZIKV and poxvirus is elicited by a two-dose regimen using DNA and non-replicating vaccinia virus-based vaccine candidates

(2019) Ying Zhan et al.   VACCINE

The Novel Replication-defective Vaccinia Virus (Tiantan Strain)–based Hepatitis C Virus Vaccine Induces Robust Immunity in Macaques

(2013) Bo Wen et al.   MOLECULAR THERAPY